Header cover image

German (DAX) Pharma Industry Analysis

UpdatedJan 31, 2023
DataAggregated Company Financials
Companies9
  • 7D0.9%
  • 3M12.7%
  • 1Y0.6%
  • YTD10.1%

The Pharma industry has stayed flat over the last week. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 7.7% annually.

Industry Valuation and Performance

Has the German Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 31 Jan 2023€142.7b€72.8b€8.4b15x17.1x2x
Thu, 29 Dec 2022€129.3b€72.8b€8.4b14.9x15.4x1.8x
Sat, 26 Nov 2022€134.0b€72.8b€8.4b17x16x1.8x
Mon, 24 Oct 2022€121.1b€70.5b€7.8b13.1x15.6x1.7x
Wed, 21 Sep 2022€125.8b€70.5b€7.8b15.3x16.2x1.8x
Fri, 19 Aug 2022€135.7b€70.5b€7.8b13.7x17.4x1.9x
Sun, 17 Jul 2022€133.9b€67.8b€5.6b23.8x23.8x2x
Tue, 14 Jun 2022€138.2b€67.8b€5.6b22.9x24.6x2x
Thu, 12 May 2022€134.1b€67.2b€5.5b24.1x24.4x2x
Sat, 09 Apr 2022€150.7b€64.8b€4.2b29.6x35.8x2.3x
Mon, 07 Mar 2022€130.4b€63.7b€3.4b27.9x38x2x
Wed, 02 Feb 2022€143.1b€63.1b€3.1b31.8x46.7x2.3x
Fri, 31 Dec 2021€150.3b€63.1b€3.1b36x49x2.4x
Sun, 28 Nov 2021€146.7b€63.1b€3.1b36.9x47.9x2.3x
Tue, 26 Oct 2021€140.9b€61.2b-€4,717,516,252.0038.8x-29.9x2.3x
Thu, 23 Sep 2021€137.0b€61.2b-€4,716,670,252.0031.5x-29x2.2x
Sat, 21 Aug 2021€140.9b€61.2b-€4,716,670,252.0032.8x-29.9x2.3x
Sat, 05 Jun 2021€119.1b€59.6b-€12,511,451,517.0032.3x-9.5x2x
Tue, 09 Mar 2021€111.3b€59.8b-€13,556,792,870.0029.4x-8.2x1.9x
Mon, 30 Nov 2020€109.1b€60.3b-€14,034,964,373.3830.9x-7.8x1.8x
Thu, 03 Sep 2020€106.9b€61.3b-€5,793,814,704.0031.3x-18.4x1.7x
Sun, 07 Jun 2020€107.2b€61.7b€4.3b29.9x25.1x1.7x
Sat, 29 Feb 2020€113.7b€60.5b€3.8b26.6x30.1x1.9x
Price to Earnings Ratio

33x


Total Market Cap: €124.4bTotal Earnings: €3.8bTotal Revenue: €60.5bTotal Market Cap vs Earnings and Revenue0%0%0%
German Pharma Industry Price to Earnings3Y Average 7.4x202120222023
Current Industry PE
  • Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 16.8x which is higher than its 3-year average PE of 8.1x.
  • The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 30% per year over the last three years.
  • Revenues for these companies have grown 6.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market0.26%
Healthcare0.31%
Pharma0.89%
Pharma0.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BAYN Bayer€56.901.7%
+€923.5m
5.7%PE11.9x
MRK MERCK Kommanditgesellschaft auf Aktien€193.550.4%
+€369.6m
-0.2%PE24.2x
93M1 MPH Health Care€15.102.7%
+€1.7m
-39.1%PB0.4x
HIGH Cantourage Group€10.360.4%
+€475.0k
n/an/a
SBX SynBiotic€11.300.7%
+€293.9k
-50.4%PS4.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

93M1

€15.10

MPH Health Care

7D

2.7%

1Y

-39.1%

BAYN

€56.90

Bayer

7D

1.7%

1Y

5.7%

PSG

€25.80

PharmaSGP Holding

7D

-0.8%

1Y

10.3%

DMP

€38.16

Dermapharm Holding

7D

-1.3%

1Y

-46.7%

B8F

€1.37

Biofrontera

7D

-2.8%

1Y

1.9%

SBX

€11.30

SynBiotic

7D

0.7%

1Y

-50.4%

APPH

€8.14

Apontis Pharma

7D

-4.9%

1Y

-55.8%